title: [Cognitive impairment in depression and potential applications of antidepressants with procognitive effects].
abstract: The characteristics of cognitive impairment in depression are reviewed. Data of literature indicate that cognitive impairment may serve as a predictor of depression recurrence and poor prognosis of antidepressant therapy. In this view, we consider the importance of assessment of cognitive impairment and differential use of medications with precognitive effect (bupropion, vorteoxetine and some SSRI antidepressants as well as fluvoxamine, which is a potent agonist of the sigma-1-receptor).
authors.affiliation: Moskovskiĭ NII psikhiatrii Minzdrava Rossii, Moskva.
authors.forename: A E
authors.initials: AE
authors.lastname: Bobrov
authors.affiliation: Fakul'tet usovershenstvovaniia vracheĭ Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva.
authors.forename: L A
authors.initials: LA
authors.lastname: Krasnoslobodtseva
authors.affiliation: Fakul'tet usovershenstvovaniia vracheĭ Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva.
authors.forename: E M
authors.initials: EM
authors.lastname: Mutnykh
authors.affiliation: Moskovskiĭ NII psikhiatrii Minzdrava Rossii, Moskva.
authors.forename: A A
authors.initials: AA
authors.lastname: Kursakov